Meningococcal Disease Vaccine - Global and China Top Players Market Share and Ranking 2023

Tables and Figures

Table 1. Meningococcal Disease Vaccine Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Meningococcal Disease Vaccine Market Restraints
Table 3. Meningococcal Disease Vaccine Market Trends
Table 4. Meningococcal Disease Vaccine Industry Policy
Table 5. Global Meningococcal Disease Vaccine Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Meningococcal Disease Vaccine Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Meningococcal Disease Vaccine Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Meningococcal Disease Vaccine Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Meningococcal Disease Vaccine Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Meningococcal Disease Vaccine Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Meningococcal Disease Vaccine Mergers & Acquisitions, Expansion Plans
Table 12. Global Meningococcal Disease Vaccine Manufacturers Product Type
Table 13. Head Office and Meningococcal Disease Vaccine Production Site of Key Manufacturer
Table 14. Meningococcal Disease Vaccine Capacity of Major Manufacturers and Future Plan
Table 15. China Meningococcal Disease Vaccine Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Meningococcal Disease Vaccine Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Meningococcal Disease Vaccine Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Meningococcal Disease Vaccine Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Meningococcal Disease Vaccine Production by Region, 2018-2023, (K Units)
Table 20. Global Meningococcal Disease Vaccine Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Meningococcal Disease Vaccine Upstream (Raw Materials)
Table 22. Global Meningococcal Disease Vaccine Typical Customers
Table 23. Meningococcal Disease Vaccine Typical Distributors
Table 24. By Type, Global Meningococcal Disease Vaccine Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Meningococcal Disease Vaccine Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Meningococcal Disease Vaccine Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Meningococcal Disease Vaccine Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Meningococcal Disease Vaccine Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Meningococcal Disease Vaccine Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Meningococcal Disease Vaccine Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Meningococcal Disease Vaccine Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Meningococcal Disease Vaccine Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Meningococcal Disease Vaccine Sales Quantity Market Share, 2018-2029
Table 34. AstraZeneca Company Information, Head Office, Market Area, and Industry Position
Table 35. AstraZeneca Meningococcal Disease Vaccine Models, Specifications, and Application
Table 36. AstraZeneca Meningococcal Disease Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. AstraZeneca Company Profile and Main Business
Table 38. AstraZeneca Recent Developments
Table 39. Johnson & Johnson Company Information, Head Office, Market Area, and Industry Position
Table 40. Johnson & Johnson Meningococcal Disease Vaccine Models, Specifications, and Application
Table 41. Johnson & Johnson Meningococcal Disease Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Johnson & Johnson Company Profile and Main Business
Table 43. Johnson & Johnson Recent Developments
Table 44. Mylan N.V Company Information, Head Office, Market Area, and Industry Position
Table 45. Mylan N.V Meningococcal Disease Vaccine Models, Specifications, and Application
Table 46. Mylan N.V Meningococcal Disease Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Mylan N.V Company Profile and Main Business
Table 48. Mylan N.V Recent Developments
Table 49. Teva Pharmaceutical Industries Ltd Company Information, Head Office, Market Area, and Industry Position
Table 50. Teva Pharmaceutical Industries Ltd Meningococcal Disease Vaccine Models, Specifications, and Application
Table 51. Teva Pharmaceutical Industries Ltd Meningococcal Disease Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Teva Pharmaceutical Industries Ltd Company Profile and Main Business
Table 53. Teva Pharmaceutical Industries Ltd Recent Developments
Table 54. Pfizer Inc Company Information, Head Office, Market Area, and Industry Position
Table 55. Pfizer Inc Meningococcal Disease Vaccine Models, Specifications, and Application
Table 56. Pfizer Inc Meningococcal Disease Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Pfizer Inc Company Profile and Main Business
Table 58. Pfizer Inc Recent Developments
Table 59. GlaxoSmithKline plc Company Information, Head Office, Market Area, and Industry Position
Table 60. GlaxoSmithKline plc Meningococcal Disease Vaccine Models, Specifications, and Application
Table 61. GlaxoSmithKline plc Meningococcal Disease Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. GlaxoSmithKline plc Company Profile and Main Business
Table 63. GlaxoSmithKline plc Recent Developments
Table 64. Novartis AG Company Information, Head Office, Market Area, and Industry Position
Table 65. Novartis AG Meningococcal Disease Vaccine Models, Specifications, and Application
Table 66. Novartis AG Meningococcal Disease Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Novartis AG Company Profile and Main Business
Table 68. Novartis AG Recent Developments
Table 69. Sanofi Company Information, Head Office, Market Area, and Industry Position
Table 70. Sanofi Meningococcal Disease Vaccine Models, Specifications, and Application
Table 71. Sanofi Meningococcal Disease Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Sanofi Company Profile and Main Business
Table 73. Sanofi Recent Developments
Table 74. Merck & Co., Inc. Company Information, Head Office, Market Area, and Industry Position
Table 75. Merck & Co., Inc. Meningococcal Disease Vaccine Models, Specifications, and Application
Table 76. Merck & Co., Inc. Meningococcal Disease Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Merck & Co., Inc. Company Profile and Main Business
Table 78. Merck & Co., Inc. Recent Developments
Table 79. F. Hoffmann-La Roche Ltd Company Information, Head Office, Market Area, and Industry Position
Table 80. F. Hoffmann-La Roche Ltd Meningococcal Disease Vaccine Models, Specifications, and Application
Table 81. F. Hoffmann-La Roche Ltd Meningococcal Disease Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. F. Hoffmann-La Roche Ltd Company Profile and Main Business
Table 83. F. Hoffmann-La Roche Ltd Recent Developments
Table 84. Baxter Company Information, Head Office, Market Area, and Industry Position
Table 85. Baxter Meningococcal Disease Vaccine Models, Specifications, and Application
Table 86. Baxter Meningococcal Disease Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Baxter Company Profile and Main Business
Table 88. Baxter Recent Developments
Table 89. BIO-MED Company Information, Head Office, Market Area, and Industry Position
Table 90. BIO-MED Meningococcal Disease Vaccine Models, Specifications, and Application
Table 91. BIO-MED Meningococcal Disease Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. BIO-MED Company Profile and Main Business
Table 93. BIO-MED Recent Developments
Table 94. Bio-Manguinhos Company Information, Head Office, Market Area, and Industry Position
Table 95. Bio-Manguinhos Meningococcal Disease Vaccine Models, Specifications, and Application
Table 96. Bio-Manguinhos Meningococcal Disease Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Bio-Manguinhos Company Profile and Main Business
Table 98. Bio-Manguinhos Recent Developments
Table 99. Walvax Biotechnology Co., Ltd Company Information, Head Office, Market Area, and Industry Position
Table 100. Walvax Biotechnology Co., Ltd Meningococcal Disease Vaccine Models, Specifications, and Application
Table 101. Walvax Biotechnology Co., Ltd Meningococcal Disease Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Walvax Biotechnology Co., Ltd Company Profile and Main Business
Table 103. Walvax Biotechnology Co., Ltd Recent Developments
List of Figures
Figure 1. Meningococcal Disease Vaccine Picture
Figure 2. Global Meningococcal Disease Vaccine Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Meningococcal Disease Vaccine Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Meningococcal Disease Vaccine Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Meningococcal Disease Vaccine Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Meningococcal Disease Vaccine Sales Quantity (K Units) & (2018-2029)
Figure 7. China Meningococcal Disease Vaccine Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Meningococcal Disease Vaccine Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Meningococcal Disease Vaccine Market Share of Global, 2018-2029
Figure 10. Global Meningococcal Disease Vaccine Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Meningococcal Disease Vaccine Key Participants, Market Share, 2022
Figure 12. Global Meningococcal Disease Vaccine Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Meningococcal Disease Vaccine Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Meningococcal Disease Vaccine Production Market Share & Forecast by Region, 2018-2029
Figure 15. Meningococcal Disease Vaccine Industry Chain
Figure 16. Meningococcal Disease Vaccine Procurement Model
Figure 17. Meningococcal Disease Vaccine Sales Model
Figure 18. Meningococcal Disease Vaccine Sales Channels, Direct Sales, and Distribution
Figure 19. Polysaccharide
Figure 20. Conjugate
Figure 21. Combination
Figure 22. By Type, Global Meningococcal Disease Vaccine Consumption Value, 2018-2029, US$ Million
Figure 23. By Type, Global Meningococcal Disease Vaccine Consumption Value Market Share, 2018-2029
Figure 24. By Type, Global Meningococcal Disease Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 25. By Type, Global Meningococcal Disease Vaccine Sales Quantity Market Share, 2018-2029
Figure 26. By Type, Global Meningococcal Disease Vaccine Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 27. Infant
Figure 28. Child
Figure 29. Aldult
Figure 30. By Application, Global Meningococcal Disease Vaccine Consumption Value, 2018-2029, US$ Million
Figure 31. By Application, Global Meningococcal Disease Vaccine Consumption Value Market Share, 2018-2029
Figure 32. By Application, Global Meningococcal Disease Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 33. By Application, Global Meningococcal Disease Vaccine Sales Quantity Market Share, 2018-2029
Figure 34. By Application, Global Meningococcal Disease Vaccine Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 35. By Region, Global Meningococcal Disease Vaccine Consumption Value Market Share, 2018-2029
Figure 36. By Region, Global Meningococcal Disease Vaccine Sales Quantity Market Share, 2018-2029
Figure 37. North America Meningococcal Disease Vaccine Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 38. By Country, North America Meningococcal Disease Vaccine Consumption Value Market Share, 2022
Figure 39. Europe Meningococcal Disease Vaccine Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 40. By Country, Europe Meningococcal Disease Vaccine Consumption Value Market Share, 2022
Figure 41. Asia Pacific Meningococcal Disease Vaccine Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 42. By Country/Region, Asia Pacific Meningococcal Disease Vaccine Consumption Value Market Share, 2022
Figure 43. South America Meningococcal Disease Vaccine Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 44. By Country, South America Meningococcal Disease Vaccine Consumption Value Market Share, 2022
Figure 45. Middle East & Africa Meningococcal Disease Vaccine Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 46. U.S. Meningococcal Disease Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 47. By Type, U.S. Meningococcal Disease Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 48. By Application, U.S. Meningococcal Disease Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 49. Europe Meningococcal Disease Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 50. By Type, Europe Meningococcal Disease Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 51. By Application, Europe Meningococcal Disease Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 52. China Meningococcal Disease Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 53. By Type, China Meningococcal Disease Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 54. By Application, China Meningococcal Disease Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 55. Japan Meningococcal Disease Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 56. By Type, Japan Meningococcal Disease Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 57. By Application, Japan Meningococcal Disease Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 58. South Korea Meningococcal Disease Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 59. By Type, South Korea Meningococcal Disease Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 60. By Application, South Korea Meningococcal Disease Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 61. Southeast Asia Meningococcal Disease Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 62. By Type, Southeast Asia Meningococcal Disease Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 63. By Application, Southeast Asia Meningococcal Disease Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 64. India Meningococcal Disease Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 65. By Type, India Meningococcal Disease Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 66. By Application, India Meningococcal Disease Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 67. Middle East & Africa Meningococcal Disease Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 68. By Type, Middle East & Africa Meningococcal Disease Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 69. By Application, Middle East & Africa Meningococcal Disease Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 70. Research Methodology
Figure 71. Breakdown of Primary Interviews
Figure 72. Bottom-up and Top-down Approaches
Figure 73. Top-down Approaches

Reason to Buy

• Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
• Highlights key business priorities in order to assist companies to realign their business strategies
• The segment that is expected to dominate the Pharma & Healthcare Market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets